Palisade Bio (PALI) Capital Expenditures (QoQ) (2010 - 2020)
Palisade Bio (PALI) Capital Expenditures (QoQ) (2010 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 200.00% |
| Jun 30, 2019 | -17.02% |
| Mar 31, 2019 | -736.61% |
| Mar 31, 2018 | 131.13% |
| Dec 31, 2017 | -199.11% |
| Sep 30, 2017 | 708.64% |
| Jun 30, 2017 | -1,439.62% |
| Sep 30, 2016 | 31,925.21% |
| Jun 30, 2016 | 102.49% |
| Mar 31, 2016 | -129.19% |
| Dec 31, 2015 | -62.94% |
| Sep 30, 2015 | 839.71% |
| Jun 30, 2015 | -209.23% |
| Mar 31, 2015 | -55.06% |
| Dec 31, 2014 | 31.91% |
| Sep 30, 2014 | -81.34% |
| Dec 31, 2013 | -195.64% |
| Sep 30, 2013 | 7,282.25% |
| Jun 30, 2013 | -200.00% |
| Mar 31, 2013 | -81.63% |